New treatment option for active lupus nephritis!
Clinical trials show that using voclosporin with mycophenolate mofetil is more effective at stopping lupus nephritis from getting worse than mycophenolate mofetil alone. This option is recommended for treating active class 3 to 5 lupus nephritis in adults. The cost-effectiveness estimates are within what NICE considers acceptable for NHS resources.
Recent Posts
Innovative Strategies of MoonLake Immunotherapeutics HS in Targeting Inflammatory Diseases
MoonLake Immunotherapeutics HS, under the leadership of CEO Jorge Santos da Silva, is reimagining traditional biotech strategies with a concentrated approach to immunotherapeutic drug development. Utilizing innovative nanobody technology, the company is making strides in treating inflammatory dis...
AMALFI Trial: How Patch-Based ECG Monitoring Could Transform Remote Atrial Fibrillation Screening
Imagine detecting a silent heart condition before it triggers a devastating stroke. The AMALFI randomized clinical trial, involving over 5,000 parti...
NICE Endorses Breakthrough Bladder Cancer Treatment for Enhanced Survival
Bladder cancer treatment has recently advanced, offering new hope for adults with advanced urothelial cancer. If you’re wondering, “What is the most effective first-line bladder cancer treatment for advanced cases in the UK right now?”—the latest update is that the National Institute for Health a...